|
|
||||||||
Papers In Press, published online ahead of print October 1, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Biochemistry and Molecular Biology, University of the Basque Country, Bilbao, Bizkaia 48080
Corresponding Author: gbpgomua{at}lg.ehu.es
It was reported previously that ceramide-1-phosphate (Cer-1-P) is mitogenic for fibroblasts [A. Gómez-Muñoz, P.A. Duffy, A. Martin, L. O'Brien, H-S. Byun, R. Bittman, and D.N. Brindley. Mol. Pharmacol. 47, 883-889 (1995); A. Gómez-Muñoz, L.M. Frago, L. Alvarez, and I. Varela-Nieto. Biochem. J. 325, 435-440 (1997). We now show that Cer-1-P blocks cell death in bone-marrow derived macrophages (BMDM) incubated in the absence of macrophage-colony stimulating factor (M-CSF), a condition known to induce apoptosis in these cells. Cell death following M-CSF withdrawal was accompanied by activation of the caspase-9/caspase-3 pathway and DNA fragmentation, both of which were inhibited by Cer-1-P. M-CSF deprivation resulted in activation of acidic sphingomyelinase (A-SMase) and increased ceramide levels in the macrophages, and Cer-1-P completely blocked these effects. Cer-1-P inhibited A-SMase activity both in intact BMDM as well as in cell homogenates, suggesting a possible direct physical interaction of Cer-1-P with the enzyme. Increasing the intracellular concentration of ceramide by treatment of BMDM with N-acetyl-sphingosine (C2-ceramide) reversed the anti-apoptotic effect of Cer-1-P. In conclusion, the data presented here demonstrate that Cer-1-P blocks apoptosis in BMDM through inhibition of A-SMase and thereby reducing ceramide generation. This adds a new dimension to the understanding of the metabolic interrelationship of ceramides and Cer-1-P, and shows how altering the balance of intracellular levels of these mediators can affect cell survival.
Revised on August 30, 2003
Accepted on September 30, 2003
Ceramide-1-phosphate blocks apoptosis through inhibition of acid sphingomyelinase in macrophages
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Graf, M. Klumpp, M. Habig, P. Rovina, A. Billich, T. Baumruker, B. Oberhauser, and F. Bornancin Targeting Ceramide Metabolism with a Potent and Specific Ceramide Kinase Inhibitor Mol. Pharmacol., October 1, 2008; 74(4): 925 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Kooijman, J. Sot, L.-R. Montes, A. Alonso, A. Gericke, B. de Kruijff, S. Kumar, and F. M. Goni Membrane Organization and Ionization Behavior of the Minor but Crucial Lipid Ceramide-1-Phosphate Biophys. J., June 1, 2008; 94(11): 4320 - 4330. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Boath, C. Graf, E. Lidome, T. Ullrich, P. Nussbaumer, and F. Bornancin Regulation and Traffic of Ceramide 1-Phosphate Produced by Ceramide Kinase: COMPARATIVE ANALYSIS TO GLUCOSYLCERAMIDE AND SPHINGOMYELIN J. Biol. Chem., March 28, 2008; 283(13): 8517 - 8526. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hinkovska-Galcheva, A. Clark, S. VanWay, J.-B. Huang, M. Hiraoka, A. Abe, M. Borofsky, R. G. Kunkel, T. Shanley, J. A. Shayman, et al. Ceramide kinase promotes Ca2+ signaling near IgG-opsonized targets and enhances phagolysosomal fusion in COS-1 cells J. Lipid Res., March 1, 2008; 49(3): 531 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Graf, B. Zemann, P. Rovina, N. Urtz, A. Schanzer, R. Reuschel, D. Mechtcheriakova, M. Muller, E. Fischer, C. Reichel, et al. Neutropenia with Impaired Immune Response to Streptococcus pneumoniae in Ceramide Kinase-Deficient Mice J. Immunol., March 1, 2008; 180(5): 3457 - 3466. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. Lamour, R. V. Stahelin, D. S. Wijesinghe, M. Maceyka, E. Wang, J. C. Allegood, A. H. Merrill Jr., W. Cho, and C. E. Chalfant Ceramide kinase uses ceramide provided by ceramide transport protein: localization to organelles of eicosanoid synthesis J. Lipid Res., June 1, 2007; 48(6): 1293 - 1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tauzin, C. Graf, M. Sun, P. Rovina, N. Bouveyron, M. Jaritz, A. Winiski, N. Hartmann, F. Staedtler, A. Billich, et al. Effects of ceramide-1-phosphate on cultured cells: dependence on dodecane in the vehicle J. Lipid Res., January 1, 2007; 48(1): 66 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Morris, L. M. Schang, and D. N. Brindley Lipid Phosphate Phosphatase-2 Activity Regulates S-phase Entry of the Cell Cycle in Rat2 Fibroblasts J. Biol. Chem., April 7, 2006; 281(14): 9297 - 9306. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Van Overloop, S. Gijsbers,, and P. P. Van Veldhoven Further characterization of mammalian ceramide kinase: substrate delivery and (stereo)specificity, tissue distribution, and subcellular localization studies J. Lipid Res., February 1, 2006; 47(2): 268 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Wijesinghe, A. Massiello, P. Subramanian, Z. Szulc, A. Bielawska, and C. E. Chalfant Substrate specificity of human ceramide kinase J. Lipid Res., December 1, 2005; 46(12): 2706 - 2716. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |